Juan Carlos Benedetti‐Isaac

Juan Carlos Benedetti‐Isaac

Auto-generated profile, based on publicly available information

Juan Carlos Benedetti‐Isaac

Medihelp Clinic Cartagena Colombia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2015 in Epilepsia
Verified
Journal Article
Open access
PDF file
JBJuan C. Benedetti‐Isaac
Juan C. Benedetti‐Isaac
MTMartin Torres‐Zambrano
Martin Torres‐Zambrano
AVAndres Vargas-Toscano
Andres Vargas-Toscano
EPEsther Perea‐Castro
Esther Perea‐Castro
GAGabriel Alcalá‐Cerra
Gabriel Alcalá‐Cerra
WLWilliam Omar Contreras Lopez
William Omar Contreras Lopez
Summary: Objectives: The aim of this study was to analyze the impact of deep brain stimulation (DBS) of the posteromedial hypothalamus (pHyp) on seizure frequency in patients with drug‐resistant epilepsy (DRE) associated with intractable aggressive behavior (IAB).Methods: Data were collected retrospectively from nine patients, who received bilateral stereotactic pHyp‐DBS for the treatment of medically intractable aggressive behavior, focusing on five patients who also had DRE. All patients were treated at the Colombian Center and Foundation of Epilepsy and Neurological Diseases—FIRE (Chapter of the International Bureau for Epilepsy), in Cartagena de Indias, Colombia from 2010 to 2014. Each case was evaluated previously by the institutional ethical committee, assessing the impact of aggressive behavior on the patient's family and social life, the humanitarian aspects of preserving the safety and physical integrity of caregivers, and the need to prevent self‐harm. Epilepsy improvement was measured by a monthly seizure reduction percentage, comparing preoperative state and outcome. Additional response to epilepsy was defined by reduction of the antiepileptic drugs (AEDs). Aggressive behavior response was measured using the Overt Aggression Scale (OAS).Results: All the patients with DRE associated with IAB presented a significant decrease of the rate of epileptic seizures after up to 4 years follow‐up, achieving a general 89.6% average seizure reduction from the state before the surgery. Aggressiveness was significantly controlled, with evident improvement in the OAS, enhancing the quality of life of patients and families.Significance: In well‐selected patients, DBS of the pHyp seems to be a safe and effective procedure for treatment of DRE associated with refractory aggressive behavior. Larger and prospective series are needed to define the pHyp as a target for DRE in different contexts.

24 February 2023 in Research in Autism Spectrum Disorders
Verified
Journal Article
Open access
JBJuanCarlos Benedetti-Isaac
JuanCarlos Benedetti-Isaac
LCLoida Camargo
Loida Camargo
FCFernando P. Cardenas
Fernando P. Cardenas
NLNorman López
Norman López

8 March 2023 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
JBJuan Carlos Benedetti‐Isaac
Juan Carlos Benedetti‐Isaac
LCLoida Camargo
Loida Camargo
MZMartin Torres Zambrano
Martin Torres Zambrano
EPEsther Perea‐Castro
Esther Perea‐Castro
ECEdgard Castillo‐Tamara
Edgard Castillo‐Tamara
NLNorman López
Norman López
Introduction: Deep brain stimulation (DBS) is a surgical technique used to manage aggression in patients who do not improve despite the use of appropriate drug treatment.Objective: The objective of this study is to assess the impact of DBS on aggressive behavior refractory to the pharmacological and behavioral treatment of patients with Intellectual Disabilities (ID).Methods: A follow‐up was conducted on a cohort of 12 patients with severe ID, undergoing DBS in posteromedial hypothalamic nuclei; evaluated with the Overt Aggression Scale (OAS), before the intervention, at 6, 12, and 18 months of medical follow‐up.Results: After the surgical procedure, there was a significant reduction in the aggressiveness of patients in the follow‐up medical evaluation at 6 months (t = 10.14; p < 0.01), 12 months (t = 14.06; p < 0.01), and 18 months (t = 15.34; p < 0.01), respect to the initial measurement; with a very large effect size (6 months: d = 2.71; 12 months: d = 3.75; 18 months: d = 4.10). From 12 months onward, emotional control stabilized and is sustained at 18 months (t = 1.24; p > 0.05).Conclusion: DBS in posteromedial hypothalamic nuclei may be an effective treatment for the management of aggression in patients with ID refractory to pharmacological treatment.

1 November 2013 in Neurología
Verified
Journal Article
Closed access
JBJ.C. Benedetti-Isaac
J.C. Benedetti-Isaac
MTM. Torres-Zambrano
M. Torres-Zambrano
JFJ. Fandiño-Franky
J. Fandiño-Franky
JDJ. Dussán-Ordóñez
J. Dussán-Ordóñez
AHA. Herrera-Trujillo
A. Herrera-Trujillo
GAG. Alcalá-Cerra
G. Alcalá-Cerra